People at an elevated risk for Plaquenil toxicity must be examined on a yearly basis. Retinal toxicity has been noted in patients after 5 to 7 years of Plaquenil medication. The purpose of the exam is to detect early any macular damage before an irreversible loss of vision or even before the symptoms of retinal toxicity surfaces.